How Recursion is leading a new era of AI-driven drug discovery AI drug discovery is not a new phenomenon – but it is evolving at an almost dizzying pace. Recursion is one of the earliest innovators in ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Tech Times on MSN
Fable 5 Laps Field on MirrorCode: Benchmark Design Explains GPT-5.5's Score Collapse
MirrorCode benchmark's August 2026 leaderboard reveals Claude Fable 5 leads all frontier models at 64%, while GPT-5.5's ...
Immersive courses. Engaged faculty. Inspired scholars. These are the heart of Miami University’s diverse arts and science curriculum. The College of Arts and Science (CAS) fosters a climate that ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results